All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Obesity and its consequences for lifelong health and well-being are an increasing burden for health systems worldwide. Globally more than 2.7 billion adults are classified as overweight or obese \[[@pone.0166076.ref001]\] and obesity has become the most important risk factor contributing to the overall burden of disease \[[@pone.0166076.ref002]\]. Adult obesity is often comorbid with many other chronic diseases, such as cardiovascular disease, type 2 diabetes, and cancer, thereby reducing life expectancy \[[@pone.0166076.ref003]\]. Furthermore, in men of reproductive age the prevalence of obesity has tripled since the early 1970's; occurring with a concomitant decline in male fertility \[[@pone.0166076.ref004]--[@pone.0166076.ref006]\]. An increased male BMI can reduce sperm count and motility, while increasing sperm DNA damage and reactive oxygen species, and disrupting mitochondrial activity \[[@pone.0166076.ref007],[@pone.0166076.ref008]\]. Consequently, male obesity is associated with increased time to conception, reduced fertilization, and impaired embryo development that culminates in reduced pregnancy rates and increased pregnancy loss \[[@pone.0166076.ref009]\].

Of significant concern, human epidemiological investigations provide evidence that an increased male BMI, or increased food intake, can lead to male transmission of non-communicable diseases to descendants. For example, a presumed excess of grandpaternal food was associated with reduced survivability \[[@pone.0166076.ref010]\] and an increased risk of diabetes \[[@pone.0166076.ref011]\] in grandchildren in a population from Northern Sweden (Överkalix). Furthermore, an increased paternal BMI is associated with increased BMI in his children \[[@pone.0166076.ref012]--[@pone.0166076.ref015]\], and paternal obesity has been associated with increased risk of autism spectrum disorder in children \[[@pone.0166076.ref016],[@pone.0166076.ref017]\]. Human studies are usually confounded by a shared genetic predisposition and/or exposure to an 'obesogenic' environment by both the father and his children \[[@pone.0166076.ref018]\].

Animal models have clearly demonstrated that programming can be paternally initiated, whereby a father's pre-conception high fat diet increases the risk of metabolic disturbances in offspring \[[@pone.0166076.ref019]--[@pone.0166076.ref021]\]. Using a mouse model of diet induced obesity, in the absence of overt signs of diabetes, we have previously demonstrated impaired reproductive and long-term metabolic health outcomes in offspring and grand-offspring \[[@pone.0166076.ref019],[@pone.0166076.ref022]\]. Furthermore this programming of offspring health occurred concomitantly with changes to the microRNA content of the father's sperm and germ cell hypomethylation \[[@pone.0166076.ref019]\].

A prime candidate mechanism, by which paternal environmental cues are passed to the next generation, are non-genetic alterations in sperm such as DNA methylation, Histone modifications, DNA damage, and in particular small non-coding RNAs (sncRNA) \[[@pone.0166076.ref023]--[@pone.0166076.ref025]\]. Mature sperm contain significant amounts of RNA, including microRNAs as a subset of small non-coding RNAs, which are transferred to the oocyte upon fertilization where they alter gene expression in the early embryo \[[@pone.0166076.ref026]--[@pone.0166076.ref029]\]. MicroRNAs are short, endogenous, single-stranded non-coding RNAs that fine tune protein expression at the post-transcriptional level by homologous binding to target mRNAs \[[@pone.0166076.ref030],[@pone.0166076.ref031]\]. While microRNAs can act by translational repression \[[@pone.0166076.ref032]\], most act via mRNA decay \[[@pone.0166076.ref031],[@pone.0166076.ref033]\]. Interestingly, microRNAs may also modulate epigenetic regulators such as DNA methyltransferases and histone deacetylases, and conversely be targets of epigenetic regulation themselves \[[@pone.0166076.ref034]\].

Sperm borne microRNAs have been demonstrated to be important for embryo development, as evidenced by embryonic arrest in embryos deficient of sperm derived microRNA \[[@pone.0166076.ref035]\] and that paternal microRNA-34c is critical for the first cleavage event \[[@pone.0166076.ref036]\]. Investigations that microinject supraphysiological amounts of single microRNAs into PN stage embryos provide direct evidence that alterations to microRNA abundance very early in embryo development are capable of inducing phenotypes in adult offspring. These phenotypes include cardiac hypertrophy (microRNA-1 \[[@pone.0166076.ref037]\]), coat colour changes (microRNA-221/222 \[[@pone.0166076.ref038]\]), embryo and offspring overgrowth (microRNA-124; \[[@pone.0166076.ref039]\]), and an obesity phenotype (microRNA-19b \[[@pone.0166076.ref040]\]). Furthermore microinjection of other multiple sncRNA or microRNA species are sufficient to recapitulate complex phenotypes, including offspring behavioural and metabolic defects induced by a father's chronic stress (9 microRNAs-- 29c, 30a, 30c, 32, 193-5p, 204, 375, 5323p, and 698; \[[@pone.0166076.ref041]\]), behavioural and metabolic defects induced by a father's early life trauma (entire sperm sncRNA content \[[@pone.0166076.ref042]\]), or an offspring acquired metabolic disorder caused by a father's over-nutrition (entire sperm tsRNA fraction \[[@pone.0166076.ref043]\]). The microinjection of 9 microRNAs changed in sperm by a father's chronic stress caused targeted degradation of stored maternal mRNAs and induced a cascade of molecular events in the early embryo that ultimately induce the adult offspring phenotype \[[@pone.0166076.ref041]\].

We therefore hypothesised that paternal diet-induced obesity during spermatogenesis can also regulate the abundance of microRNA in spermatozoa. Therefore, our aim was to utilise our mouse model of obesity to identify sperm borne microRNAs that are altered by high-fat diet induced obesity. Furthermore given that grand-offspring born to male offspring also have metabolic and reproductive phenotypes \[[@pone.0166076.ref019]\] we also aimed to establish if these same microRNAs are changed in the sperm from male offspring.

Materials & Methods {#sec002}
===================

Animals and diet {#sec003}
----------------

Male C57Bl6 mice (*aka* fathers; C57BL/6NHsd, Envigo, IN, USA) were fed either a control diet (CD *n* = 13 total; 6% fat, 19% protein, 64.7% carbohydrate; SF04-057, Specialty Feeds, Glen Forrest, Australia), or a high fat diet (HFD *n* = 14 total; 22% fat, 0.15% cholesterol, 19% protein, 49.5% carbohydrate; SF00-219, Specialty Feeds), which were otherwise matched for nutritional content. All male mice were housed individually post weaning prior to mating (including male offspring and grand-offspring), so a dominance structure was not established between males within the same litter that might affect sex hormones profiles and thus potentially skew reproductive and sperm microRNA outcomes. Animals had *ad libitum* access to feed and water for 10 weeks (5 to 15 weeks of age) and during experiments where fasting was not required. After 10 weeks on the diets (15 weeks of age) a subset of males (*aka* fathers; *n* = 9 per CD/HFD group) were mated with CD fed female C57Bl6 mice to generate male offspring, approximately 1 week prior to sperm collection. Male offspring (*n* = 9 per CD/HFD father; *ie* one male offspring per father/litter) were weaned and maintained on the CD until 15 weeks of age and mated with CD fed female C57Bl6 mice to generate the grand-offspring; then offspring sperm samples were collected post mortem.

The mice were obtained and housed individually by the University of Adelaide Laboratory Animal Services, Adelaide, Australia. All mice were maintained at 24°C on a 14 h light (lights on at 0600), 10 h dark (lights off at 2000) illumination cycle. All procedures were conducted during the light phase of the light cycle and all mice in each group were subjected to all experiments in the order in which they are described.

In all cohorts of mice each mouse had total body weight measured weekly and body composition determined by post mortem dissection and weighing each dissected tissue after 10 weeks of diet regimens (for fathers) or at 15 weeks of age for offspring. Tissues (including adipose tissue) and organs of each animal were dissected and weighed post-mortem.

Animal ethics {#sec004}
-------------

The animal ethics committee of the University of Adelaide approved all experiments, and the animals were handled in accordance with the Australian Code of Practices for the Care and Use of Animals for Scientific Purposes.

Metabolic testing {#sec005}
-----------------

Following 9--10 weeks of diet treatment in fathers (14--15 week of age), intraperitoneal glucose tolerance test (IPGTT) was performed after 6 h of fasting by intra-peritoneal (ip) injection of 2 g kg^-1^ of 25% glucose solution (Sigma, St Louis, Missouri) and then one week later intraperitoneal insulin challenge (IPTT) was performed fed after ip injection of 0.75 IU kg^-1^ insulin (Actapid®, Novo Nordisk, Bagsvaerd, Denmark). Tail blood glucose concentration was obtained by a tail vein nick and measured using a glucometer (Hemocue, Angelholm, Sweden) at timepoints 0 (pre-bolus basal), 15, 30, 60 and 120 minutes. Data is expressed as mean blood glucose concentration per group using area under curve (AUC; glucose challenge) or area above the curve (AAC) analysis (insulin challenge).

Blood hormone analysis {#sec006}
----------------------

For blood hormone measurements, male mice were fasted overnight (14 h), and a blood sample was obtained by cardiac puncture immediately prior to sacrifice, serum was immediately separated by centrifugation (4,000 rpm for 10 m at 4°C) and frozen at -80°C until further analysis. Fasting serum glucose, cholesterol, triglycerides, non-esterified fatty acids (NEFAC test) and HDL cholesterol (HDLC3) were measured in duplicates on a COBAS INTEGRA 400 (Roche Diagnostics, Basel, Switzerland). Fasting serum insulin and leptin levels were measured in duplicates by Sensitive Rat Insulin radioimmunoassay (RIA; Catalogue \# SRI 13K) and Mouse Leptin RIA, respectively (XL 85K; Millipore Corporation, Billerica, MA, USA).

Isolation of spermatozoa {#sec007}
------------------------

Spermatozoa were isolated from the vas deferens and cauda epididymis which had been dissected out of the mouse and gently squeezed into 1 ml GIVF medium (Vitrolife AB, Gothenburg, Sweden) with all tissue remnants removed, immediately after animal sacrifice and overnight fasting. Most of the GIVF/sperm solution was carefully aspirated, pelleted and resuspended/washed in 1 ml of PBS and counted as previously described \[[@pone.0166076.ref044]\] and as below, eliminating contamination of non-sperm cells. Light microscopy purity assessment confirmed samples to be entirely of spermatozoa origin. The sperm was pelleted again, snap frozen, and stored at -80°C until RNA extraction.

Sperm count and motility {#sec008}
------------------------

Spermatozoa were extracted into GIVF medium (Vitrolife AB) and allowed to swim out for 10 min at 37°C in 5% O~2~, 6% CO~2~ and 89% N~2~. Sperm concentration was determined using a Neubauer haemocytometer and sperm motility was determined by count of duplicate measures of 200 sperm \[[@pone.0166076.ref044]\] and reported as a percent of the total of motile sperm for each sample, as per the World Health Organization laboratory manual recommendations for the examination of human sperm \[[@pone.0166076.ref045]\].

RNA extraction, miRNA expression profiling and bioinformatic analysis {#sec009}
---------------------------------------------------------------------

Total RNA was isolated from 4-8x10^6^ spermatozoa for each male mouse investigated (no pooling of samples) with TRI reagent (Ambion, Waltham, MA USA), using Glycogen as a RNA carrier. RT-PCR was performed with multiplexed TaqMan primers, and the RT product pre-amplified with Megaplex PreAmp Primers. miRNA expression profiling was performed on 384-well microfluidic TaqMan Rodent MicroRNA Array cards v. 3.0 (*n* = 4 per CD/HFD group--mice from different litters were randomly allocated to the diets and then samples were randomly selected for this initial experiment) amplified on a 7900 HT Real Time PCR system. After quality control in SDS v.2.3 and RQ Manager v.1.2, the raw Ct data were quantile normalised using the normQpcrQuantile function of the R qPCRNorm package \[[@pone.0166076.ref046]\]. The degree of differential expression of the 371 mouse detectors that passed quality control were ranked using LIMMA in R ([S1 Table](#pone.0166076.s001){ref-type="supplementary-material"}). To validate the PCR array findings, qRT-PCR was performed with multiplexed TaqMan primers and the RT product pre-amplified with Megaplex PreAmp Primers, with reactions run in triplicates on a 7900 HT Real Time PCR system Data, including NTC (complete reaction without cDNA added) and no RT enzyme (complete reaction without RT enzyme) controls. miRNA expression fold change was determined by the ΔΔCT method, using the geometric mean of miR-10a and miR-195 to normalize data. Both miR-10a and miR-195 were determined to be invariable and ubiquitous endogenous controls by two approaches; cel-miR normalisation of array data (data not shown), and subsequent qPCR data ([S2 Table](#pone.0166076.s002){ref-type="supplementary-material"}). All reagents, machines and software were from Applied Biosystems, unless otherwise specified.

The Ingenuity Pathway Analysis® (IPA) tool was used to generate a list of mRNA targets experimentally confirmed to be direct targets of the microRNAs (*ie* strict filtering) that were differentially abundant in the sperm of HFD fathers. A core network analysis was then performed using only experimentally validated interactions between molecules (*ie* strict setting) and to predict the molecular networks that these mRNAs targets are known to function in.

Statistics {#sec010}
----------

All data are presented as mean ± SEM and checked for normal distribution by D\'Agostino and Pearson test (GraphPad Prism, version 5.01 for Windows, GraphPad Software, San Diego, CA, USA) as well as equal variance by a Levene's test (SPSS version 19, SPSS Inc., Chicago, IL, USA). Experimental outcomes were analysed using a paired Student's t-test, a Mann Whitney U test for non-parametric data (Graphpad Prism), or univariate general linear modelling using cohort of animals as a covariate (SPSS), when appropriate. Levels of significance were set at *p* ≤ 0.05.

Results {#sec011}
=======

A father's high fat diet models obesity in the absence of overt signs of diabetes {#sec012}
---------------------------------------------------------------------------------

We used our mouse model of high fat diet (HFD) induced obesity, where HFD consumption for 10 weeks induces obesity without any overt changes to glucose homeostasis \[[@pone.0166076.ref019],[@pone.0166076.ref022],[@pone.0166076.ref044],[@pone.0166076.ref047]\]. Although HFD fed fathers (*n* = 14) were heavier (+24.8%), as a proportion of total body weight they had increased adiposity (+46.6%). Specifically perirenal (+65.3%), gonadal (+57.2%), and omental (+65.3%) adipose depots were greater as a proportion of total body weight ([Table 1](#pone.0166076.t001){ref-type="table"}) compared with CD fed fathers (*n* = 13). Akin to human obesity, HFD feeding also increased fasted blood sera metabolite concentrations, including cholesterol (+47.3%), high density lipoprotein cholesterol low serum 3 (HDLC3; +47.5%), and non-esterified free fatty acids (FFA; +32.4%) ([Table 1](#pone.0166076.t001){ref-type="table"}) compared with CD fed fathers. This HFD regimen did not alter fasted blood sera concentrations of insulin, glucose, leptin, nor responses to a glucose or insulin bolus, compared with CD fed fathers ([Table 1](#pone.0166076.t001){ref-type="table"}). Thus the F0 metabolic phenotype was consistent with our previous use of this model of obesity, whereby the potential confounder of overt changes to glucose homeostasis, was avoided.

10.1371/journal.pone.0166076.t001

###### Fathers total body weight, body composition, and blood metabolite profile.

![](pone.0166076.t001){#pone.0166076.t001g}

  Parameter                          CD             HFD             *p* value
  ---------------------------------- -------------- --------------- -----------
  **Total body weights**             *n* = 13       *n* = 14        
    Weight (g)                       28.41 ± 0.75   35.46± 0.95     \< 0.0001
  **Adiposity--absolute mass (g)**                                  
    Perirenal fat (g)                0.21 ± 0.04    0.42 ± 0.04     0.0010
    Retro peritoneal fat (g)         0.08 ± 0.02    0.08 ± 0.03     NS
    Dorsal fat (g)                   0.36 ± 0.03    0.51 ± 0.04     0.0100
    Gonadal fat (g)                  0.88 ± 0.09    1.71 ± 0.11     \< 0.0001
    Omental fat (g)                  0.27 ± 0.03    0.56 ± 0.04     0.0001
    Sum of adipose deposits (g)      1.80 ± 0.18    3.27 ± 0.21     0.0001
  **Adiposity--relative (% TBW)**                                   
    Perirenal fat (%)                0.72 ± 0.12    1.19 ± 0.11     0.0071
    Retro peritoneal fat (%)         0.28 ± 0.08    0.21 ± 0.06     NS
    Dorsal fat (%)                   1.27 ± 0.11    1.42 ± 0.10     NS
    Gonadal fat (%)                  3.06 ± 0.26    4.81 ± 0.2178   0.0001
    Omental fat (%)                  0.72 ± 1.19    1.19 ± 0.11     0.0003
    Sum of adipose deposits (%)      6.27 ± 0.48    9.19 ± 0.41     0.0002
  **Testes weights**                                                
    Left Testis (g)                  0.08± 0.00     0.08 ± 0.00     NS
    Right Testis (g)                 0.08 ± 0.00    0.08 ± 0.00     NS
    Both Testes (g)                  0.16 ± 0.00    0.16 ± 0.00     NS
  **Blood metabolites**                                             
    Glucose (mmol/L)                 14.11 ± 1.80   13.69 ± 1.16    NS
    Cholesterol (mmol/L)             4.40 ± 0.62    6.48 ± 0.48     0.0010
    Triglyceride (mmol/L)            1.10 ± 0.14    0.98 ± 0.11     NS
    FFA (mmol/L)                     1.11 ± 0.16    1.47 ± 0.12     0.0045
    HDLC3 (mmol/L)                   3.79 ± 0.56    5.59 ± 0.43     0.0116
    Insulin (ng ml^-1^)              1.71 ± 0.48    1.38 ± 0.24     NS
    Leptin (ng ml^-1^)               24.87 ± 3.69   27.17 ± 2.98    NS
  **Glucose/Insulin testing**                                       
    GTT (AUC; mmol.min)              259 ± 18.6     238 ± 30.0      NS
    ITT (AAC; mmol.min)              294 ± 23.7     276 ± 33.1      NS

All data is presented as Mean ± SEM.

CD Control Diet, HFD High Fat Diet, *p* value determined by 2-tailed t-test, % Weight is expressed as a percent of total body weight, NS Difference between CD/HFD is not significant (*P*\>0.05), TBW total body weight, GTT glucose tolerance test, AUC area under the curve, ITT insulin tolerance test, AAC area above the curve.

High-fat diet induced obesity affects the father's reproductive system and spermatozoa quality {#sec013}
----------------------------------------------------------------------------------------------

Conventional sperm analysis showed that sperm count was unaltered by HFD feeding (8.71 ± 1.01 x 10^6^/mL for CD (*n* = 13) and 8.41 ± 0.44 x 10^6^/mL for HFD (*n* = 14)) but sperm motility was significantly reduced (CD (*n* = 13)-- 83.1 ± 2.6%; vs HFD (*n* = 14)-- 65.1 ± 4.4%; *p* = 0.0023) compared with CD fed fathers. These data confirm our previous findings that diet induced obesity impairs sperm parameters in both mouse models and in humans \[[@pone.0166076.ref009],[@pone.0166076.ref044]\].

High-fat diet induced obesity alters a father's sperm microRNA content {#sec014}
----------------------------------------------------------------------

To gain a somewhat global overview of what effect diet-induced obesity has on mouse sperm microRNA content, low density TaqMan PCR arrays were used as a screening tool for 641 murine microRNAs (*n* = 4 males per CD/HFD). The expression of 371 mouse miRNAs could be detected (raw Ct\<35) in all 8 CD/HFD samples. LIMMA analysis of quantile normalised Ct values of these 371 miRNAs ([S1 Table](#pone.0166076.s001){ref-type="supplementary-material"}) identified 28 microRNAs that were potentially differentially abundant in the sperm from HFD F0 compared with CD as determined from unadjusted *p* values (12 up-regulated and 16 down-regulated; [Table 2](#pone.0166076.t002){ref-type="table"} and full list of detected microRNAs in [S1 Table](#pone.0166076.s001){ref-type="supplementary-material"}). It must be noted that the microRNAs identified as potentially differentially abundant did not survive FDR testing, most likely due to the limited number of individual arrays used to interrogate them (*ie n* = 4 per CD/HFD F0 males) ([S1 Table](#pone.0166076.s001){ref-type="supplementary-material"}).

10.1371/journal.pone.0166076.t002

###### 28 sperm microRNAs from fathers predicted to be differentially abundant in HFD F0 sperm (*n* = 4) compared with CD sperm (*n* = 4).

![](pone.0166076.t002){#pone.0166076.t002g}

  Array Card Assay miR ID                                            CD (Ct)        HFD (Ct)       HFD FC   *p* value
  ------------------------------------------------------------------ -------------- -------------- -------- -----------
  **Up-regulated in HFD**                                                                                   
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-126-3p-4395339    21.87 ± 0.26   20.05 ± 0.32   3.53     0.004
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-135b-4395372      27.45 ± 0.31   25.77 ± 0.33   3.18     0.010
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-143-4395360       22.43 ± 0.26   20.29 ± 0.73   4.40     0.018
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-133b-4395358      27.72 ± 0.75   25.74 ± 0.29   3.97     0.029
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-136-4395641       28.38 ± 0.26   27.16 ± 0.31   2.33     0.030
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-126-5p-4373269    24.76 ± 0.49   23.32 ± 0.29   2.72     0.036
      mmu-miR-376b-4395582                                           35.90 ± 1.65   32.42 ± 0.44   11.12    0.047
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-141\#-002513      29.34 ± 0.29   28.35 ± 0.18   1.99     0.047
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-145-4395389       19.47 ± 0.49   17.82 ± 0.58   3.14     0.050
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-337-000193        31.98 ± 0.69   30.32 ± 0.36   3.18     0.050
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-30a-4373061       20.99 ± 0.46   19.81 ± 0.60   2.25     0.059
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-376a-4373347      31.12 ± 0.56   29.13 ± 0.60   4.14     0.059
  **Down-regulated in HFD**                                                                                 
      mmu-miR-669n-197143_mat                                        27.34 ± 0.43   29.54 ± 0.37   -4.60    0.005
      mmu-miR-669C-002646                                            28.87 ± 0.47   30.79 ± 0.28   -3.79    0.008
      mmu-miR-669l-121149_mat                                        29.96 ± 0.51   32.14 ± 0.44   -4.53    0.010
      mmu-miR-150-4373127                                            16.81 ± 0.33   18.27 ± 0.21   -2.77    0.011
      mmu-miR-467H-002809                                            31.25 ± 0.65   34.65 ± 1.07   -10.56   0.015
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-1961-197391_mat   32.17 ± 0.51   34.97 ± 0.93   -7.00    0.018
      [\*](#t002fn003){ref-type="table-fn"}mmu-miR-184-4373113       19.78 ± 0.26   21.00 ± 0.32   -2.32    0.031
      mmu-miR-466a-3p-002586                                         27.05 ± 0.44   28.37 ± 0.21   -2.49    0.033
      mmu-miR-672-4395438                                            22.93 ± 0.22   23.87 ± 0.13   -1.93    0.036
      mmu-miR-412-002575                                             32.94 ± 0.31   34.30 ± 1.14   -2.57    0.039
      mmu-miR-669D-002808                                            28.82 ± 0.61   30.60 ± 0.49   -3.42    0.040
      mmu-miR-139-3p-4395676                                         31.59 ± 0.99   35.01 ± 1.34   -10.77   0.045
      mmu-miR-1969-121131_mat                                        29.40 ± 0.21   30.66 ± 0.20   -2.38    0.051
      mmu-miR-879\#-002473                                           32.43 ± 0.58   35.61 ± 0.54   -9.04    0.053
      mmu-miR-92a-4373013                                            18.77 ± 0.37   19.53 ± 0.47   -1.69    0.054
      mmu-miR-466b-3-3p-002500                                       26.72 ± 0.34   27.90 ± 0.21   -2.26    0.059

*p* value (not FDR adjusted) ranked normalised Ct values are given for the 12 up-regulated and 16 down-regulated murine microRNAs as indicated by Taqman miRNA PCR array cards. All data is presented as Mean ± SEM. Mean dCt were derived from the geometric mean of mmu-miR-10a-5p and mmu-miR-195-5p (the least variable microRNAs across all samples). A full list of microRNA detectors can be found in [S1 Table](#pone.0166076.s001){ref-type="supplementary-material"}.

CD Control Diet, HFD High Fat Diet, FC fold change (of HFD vs CD by ΔΔCt method), *p* value from LIMMA analysis of normalised Ct values.

\* Confirmed as differentially abundant by subsequent qPCR interrogation in an extended cohort of F0 mice.

To build on the preliminary array findings, individual Taqman microRNA qPCR assays for all 28 candidate microRNAs were performed on the sperm from a larger sample that included both the samples used for the array (*n* = 4 per CD/HFD F0 males) and additional males from a total of three separate cohorts of mice (*n* = 13 CD fed; *n* = 14 HFD fed). This included a subset of a cohort we had previously published that demonstrated transgenerational transmission of reproductive and metabolic phenotypes into offspring and grand-offspring due a paternal HFD \[[@pone.0166076.ref019],[@pone.0166076.ref022]\]. This confirmed differential abundance of 13/28 of these miRNAs; 11 were up-regulated (mmu-miR-126-3p, 135b-3p, 143-3p, 133b-3p, 136-5p, 126-5p, 141-5p, 145a-5p, 337-3p, 30a-5p, and 376a-3p) and 2 were down-regulated (mmu-miR-184-3p, and 1961) ([Fig 1](#pone.0166076.g001){ref-type="fig"}, [S2 Table](#pone.0166076.s002){ref-type="supplementary-material"}). It must be noted that only 13/28 microRNAs were confirmed as altered in the larger cohort ([Fig 1](#pone.0166076.g001){ref-type="fig"}, [Table 2](#pone.0166076.t002){ref-type="table"}, [S2 Table](#pone.0166076.s002){ref-type="supplementary-material"}), presumably due to the limited sample size of the initial cohort or variation between individual males/cohorts. Interestingly, we note a distinct difference in the proportion of microRNAs identified by the array and confirmed as differentially abundant in the up-regulated list (11/12 confirmed) compared with the down-regulated (2/16) list.

![The abundance of the 13 sperm borne microRNAs by qPCR in the sperm of the (A) CD or HFD fed fathers and the (B) male offspring born to by either CD or HFD fed fathers.\
Fold change (FC); vs (A) CD fathers or (B) offspring born to CD fathers by ΔΔCt method) of each microRNA is given for the (A) F0 males fed the CD (*n* = 13) or HFD (*n* = 14; from 3 separate cohorts) and the (B) F1 males born to either CD (*n* = 9; black bars) or HFD (*n* = 9; white bars) fathers. The (A) geometric mean of mmu-miR-10a-5p and mmu-miR-195-5p or (B) mmu-miR-10a-5p alone was used as a reference microRNA (the least variable microRNA(s) across all samples in the present experimental setup). *p* values denoted \[\* *p* \< 0.05; \*\**p* \< 0.01\] are derived from (A) univariate general linear modelling or (B) no significant differences were detected by a Student's T test. Data is presented a means ± SEM.](pone.0166076.g001){#pone.0166076.g001}

All data were normalised to the expression of two reference microRNAs (mmu-miR-10a-5p and mmu-miR-195a-5p) that we found to be invariable and ubiquitous endogenous in the Taqman PCR array data set and then validated by the individual Taqman qPCR assays in the extended cohort ([S2 Table](#pone.0166076.s002){ref-type="supplementary-material"}). The small non-coding RNA (U6) frequently used for normalising microRNA varied more than 10a-5p and 195a-5p across our treatment groups in our hands ([S2 Table](#pone.0166076.s002){ref-type="supplementary-material"}), albeit not significantly different between CD/HFD fathers. This suggests that mmu-miR-10a-5p and mmu-miR-195a-5p are potentially better endogenous controls than U6 for investigating microRNA content in mouse sperm in the present experimental setup.

In Addition 53 mouse sperm microRNAs were only detected in the sperm from either CD or HFD fed fathers ([S3 Table](#pone.0166076.s003){ref-type="supplementary-material"}) using a Ct of 35 as detection limit cut-off. Interestingly 13/53 were detected only in the sperm from CD fed fathers; whilst the remaining 40/53 were only detected in the sperm form HFD fed fathers.

A father's high-fat diet does not alter the same subset of sperm microRNAs in offspring due to variable abundance {#sec015}
-----------------------------------------------------------------------------------------------------------------

Many paternal environmental challenges have been demonstrated to initiate transgenerational effects and epigenetic disturbances in offspring, such as endocrine disruptors \[[@pone.0166076.ref048]\], stress \[[@pone.0166076.ref049]\], pain \[[@pone.0166076.ref050]\], and nutrition \[[@pone.0166076.ref019],[@pone.0166076.ref021],[@pone.0166076.ref022],[@pone.0166076.ref051]\]. We aimed to investigate whether a polygenic disease (*ie* diet induced obesity) would have the same impact on sperm microRNA content in the F1 males, who themselves have metabolic disturbances without increased adiposity. We have previously reported that the grand-offspring born through the male offspring lineage also have metabolic and reproductive disturbances (41.4 ± 10.13% decrease in serum leptin, 53.2 ± 29.99% gain in adipose tissue, insulin resistance, 33.0 ± 11.06% decrease in sperm motility, 7.2 ± 1.84% increase in sperm reactive oxygen species (ROS), and 16.2 ± 7.13% increase in oocyte ROS) that have some phenotypic overlap with those of the male offspring investigated here (6.4 ± 1.94% increase to total body weight, 22.7 ± 11.0% in serum leptin, reduced glucose clearance, insulin resistance, 17.2 ± 9.86% decrease to sperm motility, 18.0 ± 1.23% increase in sperm ROS, 38.9 ± 6.95% decrease in sperm-oocyte binding, 150.0 ± 75.12% increase in sperm DNA damage, and 80.9 ± 13.81% decrease in oocyte fertilisation) \[[@pone.0166076.ref019],[@pone.0166076.ref022]\]. Thus the 13 sperm borne microRNAs dysregulated by a father's HFD were interrogated in the sperm from the male offspring, despite their lack of exposure to a HFD and overt obesity. Consistent with another report of transmission of behavioural disturbances to offspring due to paternal stress, where the same microRNAs altered in the fathers sperm due to stress were not altered in the offspring's sperm despite behavioural phenotypes \[[@pone.0166076.ref042]\], in our obese model none of microRNAs altered in the fathers showed signs of dysregulation in male offspring's sperm ([Fig 1](#pone.0166076.g001){ref-type="fig"}). The lack of difference between offspring born to CD/HFD fathers was presumably due to the large variance observed in the abundance of the microRNAs in the sperm from both groups of offspring.

Molecular pathways targeted by differentially abundant sperm microRNAs in fathers due to a HFD {#sec016}
----------------------------------------------------------------------------------------------

An Ingenuity Pathway Analysis® with strict filtering and analysis settings was used to both (i) generate a list of 311 experimentally confirmed mRNA targets ([S4 Table](#pone.0166076.s004){ref-type="supplementary-material"}) of the 13 microRNAs that were differentially abundant in the sperm of HFD fathers and (ii) to predict (using a strict analysis) the molecular networks that these mRNAs operate in. The top 5 ranked molecular networks identified by this analysis, and presumably targeted post fertilisation by these sperm borne microRNAs within the embryo, included diseases and functions such as cell death and survival, cancer, cellular development, organismal development, infectious diseases/immune response, cellular growth and proliferation, and embryonic development ([Table 3](#pone.0166076.t003){ref-type="table"}). P53 was identified as the highest ranked upstream regulator of these networks.

10.1371/journal.pone.0166076.t003

###### The top 5 ranked molecular networks identified by Ingenuity pathway analysis.

![](pone.0166076.t003){#pone.0166076.t003g}

  \#   Molecules in Network                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     IPA Score   Focus Molecules   Top Diseases and Functions
  ---- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------- ----------------- ----------------------------------------------------------------------------------
  1    [**Akt**]{.ul}, [**AURKB**]{.ul}, [**BCL2**]{.ul}, [**BCL6**]{.ul}, [**BECN1**]{.ul}, [**CARHSP1**]{.ul}, [**COL1A2**]{.ul}, [**CSNK1D**]{.ul}, ERK1/2, [**F11R**]{.ul}, [**HMOX1**]{.ul}, [**HRAS**]{.ul}, [**IDH1**]{.ul}, [**IGF1R**]{.ul}, [**IGF2BP1**]{.ul}, [**IGFBP5**]{.ul}, [**IRS1**]{.ul}, [**JAK2**]{.ul}, [**KRAS**]{.ul}, [**NRAS**]{.ul}, [**PAFAH1B2**]{.ul}, [**PRIM1**]{.ul}, [**Ras**]{.ul}, [**RB1CC1**]{.ul}, [**RHOB**]{.ul}, [**RTKN**]{.ul}, STAT5a/b, [**TOM1**]{.ul}, [**TOP2A**]{.ul}, [**TP53**]{.ul}, [**TYMS**]{.ul}, [**UHRF1**]{.ul}, [**UNG**]{.ul}, [**VASN**]{.ul}, [**VIM**]{.ul}   50          32                Cancer, Organismal Injury and Abnormalities, Reproductive System Disease
  2    Ap1, [**BCL2L1**]{.ul}, [**CASP3**]{.ul}, [**CASP9**]{.ul}, [**CCNA2**]{.ul}, [**CCND1**]{.ul}, [**CDC25A**]{.ul}, [**CDK4**]{.ul}, [**CDK6**]{.ul}, [**DFFA**]{.ul}, [**EIF4E**]{.ul}, [**FLI1**]{.ul}, [**HMGA1**]{.ul}, Hsp90, [**JUN**]{.ul}, [**KLF4**]{.ul}, [**KLF5**]{.ul}, [**LIN28A**]{.ul}, [**MAPK12**]{.ul}, [**MDM2**]{.ul}, [**MET**]{.ul}, [**MYC**]{.ul}, [**NFATC2**]{.ul}, [**PKM**]{.ul}, [**PLK1**]{.ul}, [**PRDM1**]{.ul}, [**PTGS2**]{.ul}, Rb, [**RHOA**]{.ul}, [**RUNX2**]{.ul}, [**SRF**]{.ul}, [**TAGLN**]{.ul}, [**THBS1**]{.ul}, [**TLR4**]{.ul}, [**WNT5A**]{.ul}                          50          32                Cellular Development, Cellular Growth and Proliferation, Cell Death and Survival
  3    14-3-3, ADCY, [**AKT2**]{.ul}, AMPK, Ap1, [**ATRX**]{.ul}, Cg, [**CTGF**]{.ul}, ERK, ESR1/2, [**GNAI2**]{.ul}, [**HMGA1**]{.ul}, [**IDH1**]{.ul}, [**KCNQ1**]{.ul}, [**KLF15**]{.ul}, [**KRT19**]{.ul}, [**MET**]{.ul}, [**MUC1**]{.ul}, [**NEDD4**]{.ul}, [**PARP**]{.ul}, Pka, PP2A, PRKAA, PTPRK, APH1A/B, [**SFRP4**]{.ul}, [**SPRED1**]{.ul}, [**STRN**]{.ul}, [**TGFBR1**]{.ul}, [**UBE2I**]{.ul}, [**UGT8**]{.ul}, Vegf, [**VEGFA**]{.ul}, [**VIM**]{.ul}, [**WNT5A**]{.ul}                                                                                                                                       30          22                Cellular Movement, Cancer, Endocrine System Disorders
  4    [**CASP3**]{.ul}, [**CCNA2**]{.ul}, [**CDK4**]{.ul}, Ces, [**DFFA**]{.ul}, [**DNMT3A**]{.ul}, E2F1, [**EIF4E**]{.ul}, [**FLI1**]{.ul}, Hnrnpa1, KIF20A, [**KLF5**]{.ul}, [**MAPK7**]{.ul}, [**MAPK12**]{.ul}, MCM6, [**MDM2**]{.ul}, ME2, MPG, [**MYC**]{.ul}, NR2E1, [**PLK1**]{.ul}, PPARA, [**PRC1**]{.ul}, SRM, [**TOP2A**]{.ul}, TOP2B, YY1                                                                                                                                                                                                                                                                         26          16                Infectious Diseases, Organismal Development, Cellular Development
  5    [**ALOX5AP**]{.ul}, [**APC**]{.ul}, ATG10, ATG2B, ATG4A, ATG4C, BMP1, CAPNS1, CTNNB1, [**CYP2A6**]{.ul} (includes others), DIAPH3, [**F11R**]{.ul}, FBLN2, FEN1, FSTL3, HIPK2, [**IGFBP5**]{.ul}, [**KRT7**]{.ul}, [**MDFI**]{.ul}, MMP23B, PSAP, [**RTKN**]{.ul}, [**SMAD5**]{.ul}, [**SPTB**]{.ul}, [**TOM1**]{.ul}, [**TP53**]{.ul}, TP63, [**UNG**]{.ul}, USO1, USP9X, UVRAG, VAMP4, [**VASN**]{.ul}, [**VEGFA**]{.ul}, VMP1                                                                                                                                                                                         22          14                Embryonic Development, Tissue Morphology, Cancer

IPA ingenuity pathway analysis was limited to experimentally validated mRNA targets of the sperm mircoRNAs with altered abundance due to a father's HFD. Molecules that are in bold/underlined font are experimentally validated targets of the sperm microRNAs with altered abundance due to a HFD.

Discussion {#sec017}
==========

The 13 sperm borne miRNAs differentially regulated in a mouse model of paternal obesity may act as epigenetic signals transmitted to offspring, by targeting maternally stored mRNA transcripts in the fertilised egg, initiating a cascade of molecular events that reprogram embryonic development that ultimately impairs the long term metabolic and reproductive health of adult offspring. Furthermore, despite grand-offspring mice born to the male offspring displaying some similarities in metabolic and reproductive phenotypes to their offspring fathers, there was limited evidence that any of these microRNAs were also dysregulated in the offspring's sperm. It must be noted that no dysregulation was observed in the sperm of the offspring presumably due to the variation of microRNA abundance detected within both groups of offspring. This suggests that either a different set of sperm borne microRNAs or other epigenetic/genetic marks are transmitted to grand-offspring that induce these phenotypes and that father to offspring signals may also comprise of more than sperm microRNAs. Taken together this implies that the set of sperm borne microRNAs identified as altered in these fathers' sperm that were associated with programming in offspring, might be unique to the obese state, as male offspring born to obese fathers using this model of obesity were not themselves obese \[[@pone.0166076.ref019]\].

Of the four sperm microRNAs (mmu-miR-133b-3p, -196a-5p, 205-5p, 340-5p) that we previously reported as altered in fathers sperm due to this HFD regimen \[[@pone.0166076.ref019]\], miR-133b-3p was confirmed as up-regulated to a similar 3x fold increase. A further two (miR-205-5p, miR-340-5p) agreed with the direction of regulation due to a father's HFD, but did not reach statistical significance due to the large variance detected across the limited sample size used in the Taqman array (*ie n* = 4), mainly between the HFD father samples. The last microRNA (miR-196a-5p) did not pass the quality test applied to all raw data prior to the LIMMA analysis, but interestingly it was detected in HFD fed fathers sperm but not in CD fed fathers (using a 35 Ct cut-off limit of detection), consistent with a large up-regulation as previously reported. This may be due to the multiplex nature of the method used for cDNA generation that might result in inconsistent representation of specific microRNAs in the cDNA versus a single assay in the subsequent qPCRs, or the variance of some microRNAs between the multiple cohorts. Thus highlighting the importance of qPCR confirmation of array data with a larger sample size from multiple cohorts.

It is possible that the sperm microRNAs that are differentially abundant in obese fathers enact their presumed perturbation to cellular functions by targeting maternally stored mRNAs post-fertilisation, as has recently been demonstrated for transmission of paternal stress cues \[[@pone.0166076.ref041]\]. Although, it must be noted that the microinjection of these microRNAs into early embryos would be required to provide direct causality of mRNA dysregulation, altered embryo development, and recapitulation of offspring phenotype. The top networks that the differentially abundant sperm borne microRNAs have been experimentally confirmed to modulate include functions such as cell death and survival, cellular development, cellular growth and proliferation, and embryonic development. Impairment to these functions might result in the delayed development, increased apoptosis, reduced cell numbers, and altered cell allocation that has been previously reported to occur in embryos fathered by males subjected to the same dietary regimen\[[@pone.0166076.ref052]--[@pone.0166076.ref054]\]. Part of the embryonic phenotype (of offspring) may well result from microRNA-145's regulation of pluripotency, that has been demonstrated in human embryonic stem cells acting via repression of *OCT4*, *SOX2* and *KLF4* \[[@pone.0166076.ref055],[@pone.0166076.ref056]\]. Moreover microRNA-143/145 have been demonstrated to be delivered by sperm, insofar as they were not detectable in oocytes but were present in both sperm and in early embryos soon after fertilisation \[[@pone.0166076.ref036]\]. Since sperm presumably deliver these microRNAs to the oocyte at fertilisation, their increased abundance in the sperm from obese fathers potentially leads to an increased inhibition of *OCT4*, *SOX2* and *KLF4*, reducing pluripotency within these embryos, which has important ramifications for the development of the pluripotent epiblast, which will ultimately develop into the fetal pole. A high fat diet has been shown to reduce the formation of the epiblast and also increases the amount of pregnancy loss in this mouse model of obesity \[[@pone.0166076.ref054]\]. Furthermore microRNA-135b (increased in obese males' sperm) is a member of a family of microRNAs that target SIAH1, a protein essential to the first embryonic cell cleavage \[[@pone.0166076.ref057]\], and if its abundance is altered it has potential ramifications for the delayed cleavage observed for embryos fathered by males on the same HFD regimen \[[@pone.0166076.ref052]--[@pone.0166076.ref054]\]. Importantly, as these sperm microRNAs might potentially disrupt molecular pathways such as endocrine system disorders, tissue morphology, organismal injury & abnormalities, immune responses, and reproductive system disease this might initiate a post fertilisation molecular cascade that ultimately has a bearing on the subsequent health of offspring. This could possibly then partially explain the glucose homeostasis, adiposity, and reproductive defects evident in offspring fathered by males exposed to the same HFD regimen \[[@pone.0166076.ref019],[@pone.0166076.ref020],[@pone.0166076.ref022],[@pone.0166076.ref058]\].

The differentially abundant sperm microRNAs may potentially also be acting upon DNA methylation post fertilisation. Indeed there are multiple lines of evidence that microRNAs can alter methylation patterns. Specifically microRNA-126-3p (increased in sperm from HFD fathers) binds the 3′-untranslated region of *DNMT1* mRNA, reducing its expression and leading to hypomethylation \[[@pone.0166076.ref059]\]. Interestingly, hypomethylation occurs in the germ cells of male mice exposed to the same HFD regimen \[[@pone.0166076.ref019]\]. MicroRNA-143 has been experimentally confirmed to represses *DNMT3A* expression in colon and breast cancer cell lines \[[@pone.0166076.ref060],[@pone.0166076.ref061]\], and inhibit growth by causing apopotosis in leukaemia cells \[[@pone.0166076.ref062]\]. But whether micro-RNA-143-3p (increased in sperm from HFD fathers) is also capable of these functions remains to be determined. Furthermore microRNA-30a/microRNA-135b and microRNA-133b are also predicted to target *DNMT3A* and *DNMT3B*, respectively, for mRNA degradation. Overall the predicted targeting of components of the DNA methylation machinery provides the means for longer term changes to gene expression within the embryo and potentially even subsequent offspring. Furthermore given that offspring sperm does not overtly demonstrate the same compliment of differentially abundant microRNAs, DNA methylation might also be important for the phenotypic transmission from offspring to grand-offspring.

The tumour suppressor p53 is known to enhance post-transcriptional maturation of multiple miRNAs, including microRNA-143/microRNA-145 (increased in the sperm from HFD fathers), as a response to DNA damage \[[@pone.0166076.ref063]\]. Interestingly increased DNA damage has been previously reported to result from the model of male obesity used in this study \[[@pone.0166076.ref022],[@pone.0166076.ref044],[@pone.0166076.ref064]\] and this potentially triggers the increased abundance of p53 and thus microRNA-143/microRNA-145. This would likely occur in concert with the increase in the abundance of p53 due to diet induced obesity \[[@pone.0166076.ref065],[@pone.0166076.ref066]\], possibly resulting from p53's role in adipogenesis \[[@pone.0166076.ref067]\]. Moreover microRNA-143 is known to accelerate adipogenesis and is also increased in adipose tissue of mice fed a high fat diet \[[@pone.0166076.ref068]\]. Overall it remains possible that p53 acts upstream as a result of DNA damage and HFD consumption that ultimately leads to increased microRNA-143/microRNA-145 in sperm in HFD fathers.

MicroRNAs-145a-5p, 30a-5p, 126-3p, 184-3p, and 143-3p are the most differentially abundant as a result of diet induced obesity, perhaps indicating their potential to enact aberrant maternal mRNA decay in the embryo. Furthermore 8/13 microRNAs altered by a father's obesity are amongst the microRNAs whose abundance are most altered in sperm during epididymal transit (mmu-miR- 126-3p, 126-5p, 135b-5p, 143-3p, 145a-5p, 30a-5p, 141-5p, and 184-3p \[[@pone.0166076.ref069]\]). Thus it remains a distinct possibility that the abundance of these microRNAs might be differentially acquired in obesity during epididymal transit, as the epididymis is not as protected from environmental insults as the testis. This altered microRNA transfer may well be enacted by epididymosomes \[[@pone.0166076.ref070]\] that may result from the effect of a father's obesity, that then might also have altered microRNA content in epididymal epithelial cells, whose physiology is likely altered by systemic impacts of obesity \[[@pone.0166076.ref071]\].

Similar to our findings, the abundance of sperm borne microRNA-30a-5p was increased by a model of paternal stress \[[@pone.0166076.ref072]\]. This model of paternal stress resulted in behavioural and metabolic disturbances in offspring \[[@pone.0166076.ref041],[@pone.0166076.ref072]\], similar to the metabolic disturbances reported for offspring sired by HFD fathers \[[@pone.0166076.ref019],[@pone.0166076.ref020]\]. Interestingly HFD feeding in murine fathers tends to increase corticosterone \[[@pone.0166076.ref073]\], implying a degree of systemic stress is endured by males as a result of exposure to a HFD, which may be a common system to increase microRNA-30a-5p in sperm. Furthermore individual housing may also induce a degree of stress in mice, which might also contribute to this alteration. Thus it is possible that behavioural defects might also exist in offspring sired by HFD fathers, as observed in humans as an increased risk of autism spectrum disorders in children born to obese fathers \[[@pone.0166076.ref016],[@pone.0166076.ref017]\]. Alternatively the model of paternal stress used might also cause metabolic derangements in the fathers themselves, which is then transmitted to offspring as previously reported, as stress is a known trigger for metabolic disturbances \[[@pone.0166076.ref074]\]. Although it has been previously demonstrated that the microinjection of a single microRNA can both alter the molecular makeup of the embryo and induce phenotypic outcomes in adult offspring (*eg* microRNA-221/222 \[[@pone.0166076.ref038]\]; microRNA-1 \[[@pone.0166076.ref037]\]; microRNA-124 \[[@pone.0166076.ref039]\]; microRNA-193-5p (partial phenotype) \[[@pone.0166076.ref041]\]). It has also been demonstrated that the co-ordinate regulation of molecular pathways by multiple microRNAs \[[@pone.0166076.ref041]\], entire sperm sncRNA extract \[[@pone.0166076.ref042]\], or specific sub-classes of sncRNA fractions (*ie* the tsRNA fraction \[[@pone.0166076.ref043]\]) are capable of recapitulating a complex phenotype. Whether microinjection of the amounts of microRNA, or other sncRNA fractions, actually present in a single sperm can also induce these molecular and phenotypic changes, remains to be determined.

The array used to interrogate sperm microRNAs was limited to 641 murine microRNAs of an estimated 1,400 that are present \[[@pone.0166076.ref075]\] and did not include investigation of the broader gamut of other small non-coding RNA. Regardless it must be noted that the same array was used to detect the 9 microRNAs altered by paternal stress that when microinjected into an early embryo were sufficient to recapitulate the offspring phenotype \[[@pone.0166076.ref041],[@pone.0166076.ref072]\].

Diet and/or exercise interventions have been used in a similar model of diet induced obesity in fathers to demonstrate that this type of intervention strategy can be effective for ameliorating detrimental effects of paternal diet-induced obesity on metabolic parameters and sperm function \[[@pone.0166076.ref073]\], embryonic development \[[@pone.0166076.ref053]\], reproductive function of offspring \[[@pone.0166076.ref058]\], and metabolic health of offspring \[[@pone.0166076.ref020]\]. Moreover these interventions that mitigate the obesity in fathers occur concomitantly with a partial restoration of sperm borne microRNA content similar to that of control animals \[[@pone.0166076.ref020]\]. If the entirety of these findings are translatable to human cohorts sperm borne microRNAs could be potential readily assayable biomarkers of successful obesity interventions, to be used by obese men prior to conception to minimise detrimental health outcomes in his children.

We have demonstrated that the abundance of 13 sperm borne microRNAs are modulated by a father's consumption of a high fat diet and speculate that the transmission of this altered microRNA content to the embryo at fertilisation acts to alter the mRNA content of the embryo, as has been previously demonstrated. This altered embryonic mRNA content then acts to alter growth trajectory previously observed for embryos fertilised by obese fathers and ultimately confers sub-optimal adult metabolic and reproductive outcomes described for offspring sired by obese fathers. Although the same microRNAs are most likely not altered in the sperm of male offspring, despite the presence of metabolic/reproductive phenotypes in grand-offspring sired by the male offspring. Thus we have identified a potential mechanism that may, in part, form the basis of obesity initiated paternal programming of the first generation of offspring.

Supporting Information {#sec018}
======================

###### The degree of differential expression in a HFD father's sperm of 371 mouse quality detectors that were ranked using LIMMA in R.
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###### Sperm microRNA expression in an expanded group from 3 cohorts of CD or HFD fed fathers (CD *n* = 13; HFD *n* = 14) as determined by qPCR.
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###### Mean Cts for 53 mouse sperm microRNAs that were only detected in either in CD or HFD fed father\'s sperm.
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###### The 311 experimentally validated mRNA targets of the 13 sperm microRNAs with differential abundance due to a father's HFD and the microRNAs which target them.
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